BPC-157: Research Overview

BPC-157, short for Body Protection Compound-157, is a synthetic peptide derived from a naturally occurring protein found in human gastric juice. Consisting of 15 amino acids, it has been the subject of considerable scientific interest over the past two decades, primarily for its apparent tissue-protective properties. Researchers have explored BPC-157 across a range of in vitro and animal model studies, examining its effects on wound healing, inflammation, and cellular recovery processes.

Mechanism of Action

BPC-157 is thought to exert its effects through multiple biological pathways. Studies suggest it interacts with the nitric oxide (NO) system, influencing vascular tone and blood flow to injured tissues. It appears to upregulate growth hormone receptors and modulate the expression of genes involved in tissue regeneration. Research also points to interactions with the VEGF (vascular endothelial growth factor) pathway, which plays a key role in angiogenesis — the formation of new blood vessels. These combined mechanisms may explain the compound’s observed cytoprotective effects in preclinical models.

Key Research Areas

• Gastrointestinal Tissue Studies: BPC-157 has been extensively studied in animal models of GI tract injury, where it has shown potential to accelerate mucosal healing and reduce inflammatory markers.
• Musculoskeletal Research: Rodent studies have examined BPC-157 in models of tendon, ligament, and muscle damage, with results suggesting enhanced structural repair and collagen organization.
• Neurological Models: Preclinical research has investigated BPC-157 in models of peripheral nerve damage and central nervous system injury, with early data suggesting neuroprotective activity.
• Inflammatory Modulation: In vitro studies have documented BPC-157’s ability to suppress pro-inflammatory cytokine activity, raising interest in inflammatory disease models.

Research Applications

In laboratory settings, BPC-157 is primarily used in rodent injury models — particularly those involving surgically induced wounds, chemical-induced GI damage, or mechanical trauma to soft tissue. Researchers reconstitute the lyophilized peptide in sterile bacteriostatic water for subcutaneous or intraperitoneal administration in preclinical protocols. Its stability at room temperature (when lyophilized) and relatively straightforward reconstitution profile make it a common choice for multi-week animal studies.

Study Protocol Context

Published animal studies provide insight into the dosing parameters researchers have used when investigating BPC-157. In a 2003 study by Staresinic et al. (Journal of Orthopaedic Research, PMID 14554208), researchers administered BPC-157 at 10 µg/kg intraperitoneally once daily beginning 30 minutes post-surgery in a rat Achilles tendon transection model, continuing through Day 14. A 2006 follow-up by Krivic et al. (PMID 16583442) used the same dose and route in a tendon-to-bone reattachment model, extending the administration period through Day 21. A separate 2006 study by Staresinic et al. (PMID 16609979) examining quadriceps muscle transection used the same daily i.p. protocol across a 72-day study period. Across these studies, three dose levels were typically tested — 10 µg/kg, 10 ng/kg, and 10 pg/kg — with all three demonstrating measurable effects relative to controls.

These protocols reflect the parameters used in controlled preclinical settings and are provided here as scientific context only. They do not constitute dosing guidance for any application.

Storage and Handling

BPC-157 is supplied as a lyophilized (freeze-dried) powder for research use. It should be stored at -20°C in a dry environment away from light. Once reconstituted with bacteriostatic water, the resulting solution should be kept refrigerated at 2–8°C and used within 28 days. Freeze-thaw cycles should be avoided after reconstitution. As with all research peptides, proper aseptic technique is recommended during handling.

Available from Alpha Peptides US

Alpha Peptides US offers BPC-157 10mg for qualified research purposes. Each vial is produced to research-grade standards and accompanied by documentation for laboratory use.

This product is intended for laboratory research purposes only. It is not approved by the FDA and is not intended for human or veterinary use, diagnosis, treatment, or prevention of any condition.